PhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country’s leading biopharmaceutical researchers and biotechnology companies.

Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as Cancer, Alzheimer’s Disease, Cystic Fibrosis and Parkinson’s.

New medicines are an integral part of the healthcare system, providing doctors and their patients with safe and effective treatment options, extending and improving quality of life.

The Pharmaceutical Research and Manufacturers of America (PhRMA) was formed in 1958 to represent America’s biopharmaceutical research companies and seek essential alignment between public policy and medical research to address patient needs.

Headquartered in Washington, DC, with offices in leading biopharmaceutical research communities, PhRMA advocates in the U.S. and around the world on public policy issues critical to the discovery and development of innovative medicines.

These priorities include the increased complexity and risk of the research and development process; continued need for investment in R&D; broad access to and appropriate use of medicines; increased value for today’s patients; and the continued importance of strong intellectual property incentives for new medicines.

For More Information Please Visit:  PhRMA.org